The DTaP Vaccine: What the Manufacturer's Insert Tells Us

34
Manufactured with Casein, a Milk Protein
One of the first important things to note on the DTaP package insert is that portions of the vaccine are cultivated with casein, or milk protein. Cow milk protein is a common infant and child allergen. Any child suspected of having or diagnosed with a dairy allergy should NOT receive this vaccine. This critical information is mysteriously missing from the CDC's DTaP Vaccine Information Statement (VIS), which doctors are required by law to give to parents at the time the vaccine is administered.

Formaldehyde in the DTaP
Formaldehyde is a common ingredient in vaccines and is specifically listed here as the ingredient used to detoxify the vaccine. It has been argued that the amount is too small to be of an significant risk to recipients of the vaccine. It is used in several different industries as a fungicide, germicide, disinfectant, and preservative.

Formaldehyde is frequently used in construction materials and off-gases over time, making it one of the most common indoor pollutants. According to the National Cancer Institute, "Cancer and as a probable human carcinogen by the U.S. Environmental Protection Agency. Research studies of workers exposed to formaldehyde have suggested an association between formaldehyde exposure and cancers of the nasal sinuses, nasopharynx, and brain, and possibly leukemia."

The NCI also lists the health effects of low level exposure as "watery eyes; burning sensations of the eyes, nose, and throat; coughing; wheezing; nausea; and skin irritation. Some people are very sensitive to formaldehyde, while others have no reaction to the same level of exposure."

The Manufacturer's Studies on Efficacy
GlaxoSmithKline lists studies that determine how effective their DTaP vaccine is at preventing pertussis as defined by the World Health Organization. These two studies concluded that the DTaP vaccine is 84% and 78% effective, respectively. Studies on the vaccine's effectiveness against diphtheria and tetanus are strangely missing from the package insert.

Why The Exclusion of Youth and Adults?
The DTaP package insert specifically states that INFANRIX should not be given to anyone over the age of 7. An explanation is not given. A review of the package inserts of other brands of DTaP, including older DTP vaccines, reveals the same warning, also without explanation.

DTaP Warnings and Contraindications
The DTaP package insert warns that the vaccine should not be given if the recipient experiences any of the following with a previous dose:

-Encephalopathy such as coma, seizures, or loss of consciousness

-Progressive neurological disorder, such as spasms or epilepsy

Publish